Regenicin, Inc. (RGIN)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Sep 29, 2026
Regenicin Market Cap
Regenicin has a market cap or net worth of $153 as of October 22, 2026. It is the 52,801st most valuable company in the world and the 8,811th biggest in the United States. Its market cap has decreased by 99.00% in one year.
Market Cap
153.00
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#8,811 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since November 16, 2009, Regenicin's market cap has decreased from 2.17M to 153.00, a decrease of -99.99%. That is a compound annual growth rate of -43.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 153.00 | - |
| Dec 31, 2025 | 153.00 | -99.80% |
| Dec 29, 2022 | 76.74K | -95.00% |
| Dec 31, 2021 | 1.53M | -33.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanobac Pharmaceuticals | 250.00 |
| NanoLogix | 163.00 |
| Kiromic BioPharma | 157.00 |
| Poniard Pharmaceuticals | 150.00 |
| NexImmune | 139.00 |
| PsyBio Therapeutics | 133.00 |
| Marizyme | 132.00 |
| HEALTHeUNIVERSE | 118.00 |